Company Research
Whether you are exploring new sales opportunities or researching a new investment, FirstRain provides unique insight into important developments for C. R. Bard, Inc. (BCR). You can receive reports or configure the research engine for yourself.
Report On:
C. R. Bard, Inc. (BCR)
HEALTHCARE - Health Services - Medical Instruments & Supplies
Generated: Thursday September 15, 2011 04:05 AM
|
|
||||||||||||||||||
Quotes About C. R. Bard, Inc.
-
Update: Transvaginal mesh makers debate patient groups at the FDA advisory panel
There are clear risks associated with the transvaginal placement of mesh to treat POP,"
- William Maisel -
Boston Scientific and other transvaginal mesh makers defend their devices amid FDA probe
Boston Scientific believes that mesh products are a valuable option for surgeons who treat women with pelvic floor disorders and stress urinary incontinence and that these products offer a safe and effective alternative to non-mesh treatment options,"
- John Pedersen -
Panel mulls tougher rules for transvaginal meshes
We need to change how we do our premarket evaluations of these products,"
- Colin Pollard -
J&J-Led Vaginal Mesh Group Says FDA Should Require More Studies
The clinical effectiveness of surgical mesh for transvaginal repair of pelvic organ prolapse has not been demonstrated,"
- William Maisel -
J&J Vaginal Mesh Faces FDA Panel's Review as Lawsuits Rise
The clinical effectiveness of surgical mesh for transvaginal repair of POP has not been demonstrated,"
- William Maisel
No Comment
-
J&J Vaginal Mesh Faces FDA Panel's Review as Lawsuits Rise
Bard spokesman Scott Lowry declined to comment on about 190 lawsuits it faces over its Avaulta pelvic mesh.
- Adam Slater
Latest Company Intelligence
-
Transvaginal Mesh Failure Risk Being Reviewed by FDA Panel
AboutLawsuits.com | Sep 9,'11
An FDA advisory panel is meeting today and tomorrow to examine recent reports involving complications and failure associated with transvaginal mesh systems that are commonly used to repair pelvic organ prolapse. The FDA's Obstetrics and Gynecological Devices panel will offer guidance and recommendations to the agency about what steps could be taken to help protect women from the serious -
J&J-Led Vaginal Mesh Group Says FDA Should Require More Studies
Bloomberg Businessweek | Sep 8,'11
Sept. 8 (Bloomberg) -- Johnson & Johnson and rival makers of transvaginal meshes told Food and Drug Administration advisers they agreed on the need for more safety studies of the implants as well as labeling changes to warn of potential risks. Manufacturers including J&J and Endo Pharmaceuticals Holdings Inc. proposed that new versions of the devices require clinical trials before they -
J&J Vaginal Mesh Faces FDA Panel's Review as Lawsuits Rise
Bloomberg Businessweek | Sep 8,'11
(Adds shares trading in the 10th paragraph.) Sept. 8 (Bloomberg) -- Johnson & Johnson and C.R. Bard Inc. may have to submit more safety data on a type of surgical mesh that has led to about 500 lawsuits against the manufacturers. A panel of U.S. Food and Drug Administration advisers is meeting today and tomorrow on whether the mesh, which supports weakened muscles that can't hold a -
Insiders Bought and Sold These S&P Shares Recently
Wall St. Cheat Sheet | Aug 30,'11
Wall St. Watchdog reveals information about recent insider trades in the constituent companies of the S&P 500. Kiran Patel , who is an insider at Intuit, Inc. ( NASDAQ:INTU ), sold 100,000 shares at a cost of $44.13 for a total of $4,413,330 on Aug 22. -
S&P 500 Company Insider Trades to Know Now
Wall St. Cheat Sheet | Aug 30,'11
Wall St. Watchdog reveals information about recent insider trades in the constituent companies of the S&P 500. Martin H Loeffler , who is an insider at Amphenol Corporation ( NYSE:APH ), bought 115,300 shares at a cost of $43.31 for a total of $4,993,908 on Aug 5. -
Transvaginal Mesh Recall Urged by Consumer Group Public Citizen
AboutLawsuits.com | Aug 27,'11
The prominent consumer advocacy group Public Citizen is pushing the FDA to issue a recall for transvaginal mesh used to treat pelvic organ prolapse, citing data that suggests the bladder suspension surgery products carry a high risk of permanent injury while providing no significant benefits. In a petition filed with the FDA on Thursday, Public Citizen indicated that a transvaginal mesh
FirstRain customers use intelligent business search to find actionable insights about companies, management, and industries. You can review company briefs, quickly research a new idea or opportunity, generate personalized industry reports, or set up alerts on reasons to call. Be sure to view our sample reports below.
